Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
Products
Antibodies
ELISA and Assay Kits
Research Areas
Infectious Disease
Resources
Purchasing
Reference Material
Contact Us
Locations
Orders Processing,
Shipping & Receiving,
Warehouse
2 Shaker Rd Suites
B001/B101
Shirley, MA 01464
Production Lab
Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036
Telephone Numbers
Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565
Contact Us
Additional Contact Details
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
| Catalog Number | Size | Price |
|---|---|---|
| LS-G139366-10 | 10 µg | $281 |
| LS-G139366-50 | 50 µg | $389 |
Human TNFSF4 / OX40L / CD252 Protein (Recombinant mFc, C-terminus) (Leu29-Ala216) - LS-G139366
Human TNFSF4 / OX40L / CD252 Protein (Recombinant mFc, C-terminus) (Leu29-Ala216) - LS-G139366
Description:
TNFSF4 / OX40L / CD252 Protein LS-G139366 is a Recombinant Human TNFSF4 / OX40L / CD252 produced in Mammalian Cells Leu29-Ala216 with mFc, C-terminus tag(s). It is low in endotoxin; Less than 1.0 EU/µg protein (determined by LAL method). For Research Use Only
Toll Free North America
206-374-1102
206-374-1102For Research Use Only
Overview
Description:
TNFSF4 / OX40L / CD252 Protein LS-G139366 is a Recombinant Human TNFSF4 / OX40L / CD252 produced in Mammalian Cells Leu29-Ala216 with mFc, C-terminus tag(s). It is low in endotoxin; Less than 1.0 EU/µg protein (determined by LAL method). For Research Use Only
Specifications
Type
Recombinant Protein
Target
TNFSF4 / OX40L / CD252
Synonyms
TNFSF4 | CD134 ligand | CD134L | CD252 antigen | Glycoprotein Gp34 | OX-40L | OX40 ligand | TXGP1 | OX40L | OX4OL | CD252 | gp34 | OX40 antigen ligand
Species
Human
Modifications
Unmodified
Conjugations
Unconjugated
Tag
mFc, C-terminus
Region
Leu29-Ala216
Predicted Molecular Weight
46.8 kDa
Expression System
Mammalian Cells
Source Species
Mammal
Purification
Greater than 95% by SDS-PAGE
Usage Summary
Recombinant Human OX40 is produced by our Mammalian expression system and the targetgene encoding Leu29-Ala216 is expressed with a mFc tag at the C-terminus.
Bio-Activity
Not Tested
Endotoxin
Less than 1.0 EU/µg protein (determined by LAL method).
Presentation
Lyophilized from a sterile solution in PBS, pH 7.4.
Storage
Store lyophilized at room temperature for up to 3 weeks, or at -20°C or below. Aliquot and store reconstituted at 4°C-7°C for up to 1 week, or at -20°C or below for up to 3 months. Avoid freeze/thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
About TNFSF4 / OX40L / CD252
Publications (0)
Customer Reviews (0)
Popular TNFSF4 / OX40L / CD252 Proteins
Source:
Human
Tag:
8His, N-terminus
Source:
Human
Tag:
8His, N-terminus
Source:
Human
Tag:
6His, N-terminus
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 7/22/2024
Date Requested: 7/22/2024
